Sionna Therapeutics, Inc. (SION)

Sionna Therapeutics will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

Sionna Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Debt / Equity Ratio	-0.07	-0.09	-
Debt / EBITDA Ratio	-0.15	-0.21	-
Debt / FCF Ratio	-0.21	-0.23	-
Quick Ratio	21.22	4.79	10.01
Return on Equity (ROE)	38.85%	41.14%	57.55%
Return on Assets (ROA)	-	-90.99%	-46.06%
Return on Capital (ROIC)	46.93%	48.21%	59.17%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).